GlassScriptPhysician profile
Evan Madden
NPI 1487181210
$874.25
in general payments reported to CMS, 2019-2025
20 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.51 · 2021: $18.11 · 2022: $62.94 · 2024: $258 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $153.78 | 2024-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $105.67 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $79.57 | 2024-2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $65.62 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $58.57 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $54.28 | 2024-2025 | Rexulti |
| Abbott Laboratories | $51.09 | 2025 | Eterna |
| Glaxosmithkline, LLC. | $41.63 | 2025 | Bexsero, Arexvy, Shingrix |
| Inari Medical, INC. | $40.09 | 2021-2022 | |
| Abbvie INC. | $37.66 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.45 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.52 | 2022 | |
| Daiichi Sankyo INC. | $20.96 | 2025 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $18.44 | 2022 | |
| Karl Storz Endoscopy-America | $17.51 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.99 | 2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $15.62 | 2024 | |
| Phathom Pharmaceuticals, INC. | $14.84 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $14.53 | 2025 | Capvaxive, Gardasil 9, Enflonsia |
| Inspire Medical Systems, INC. | $14.43 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.